Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

1019206-88-2Regorafenib Monohydrate Working Standard (Secondary Reference Standard)

● Under Development

Catalogue No.:	VE0027364
CAS No.:	1019206-88-2
Mol. Formula:	C21H17ClF4N4O4
Mol. Weight:	500.83 g/mol

How can we help?

Add to RFQ list

Additional information on CAS 1019206-88-2

Parent drug

Regorafenib / Regorafenib Monohydrate

IUPAC Name

4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl]-amino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide monohydrate

Smiles

FC1=C(C=CC(OC2=CC(C(NC)=O)=NC=C2)=C1)NC(NC3=CC(C(F)(F)F)=C(Cl)C=C3)=O.O

InChI

InChI=1S/C21H15ClF4N4O3.H2O/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26;/h2-10H,1H3,(H,27,31)(H2,29,30,32);1H2

Description

Regorafenib Monohydrate Working Standard (Secondary Reference Standard), CAS 1019206-88-2, is a characterized secondary reference material provided for analytical laboratories and research organizations and is traceable to an applicable pharmacopeial reference standard such as USP, BP, JP, or Ph. Eur., as applicable. It is intended for research and analytical use. Supplied with a comprehensive certificate of analysis documenting identity by relevant analytical techniques such as mass, 1H NMR, and FT-IR, together with assay by HPLC and other applicable quality attributes such as loss on drying and residual solvents, this working standard is suitable for analytical laboratory use where consistent and well-documented secondary reference material is required.